Support is requested for the development of a Clinical Research Center (CRC) through the Research Center for Minority Institutions (RCMI) clinical research infrastructure initiative. The development of a CRC at Charles Drew University of Medicine and Science (Drew University) is viewed as a critical tool for expanding patient care oriented research opportunities for faculty, fellows, housestaff and students. Historically, clinical research Centers have played an influential role in the development medical advances, thereby setting standards for the practice of medicine and the quality of health Care. The absence of CRC's at minority institutions has created a barrier for the development of a critical mass of clinical research faculty dedicated to the investigation of those health issues that disproportionately affect minorities. In addition, the development of a CRC would foster scholarly collaboration between the University of California, Los Angeles, School of Medicine (ACLU) and ACLU-affiliated institutions and Drew University, thereby enhancing the clinical research capabilities of each institution. Patient care oriented research activities have increased at Drew University over the last five years. There are presently 6 PAS funded clinical research studies, representing the departments of Medicine, Surgery, Psychiatry and Anesthesiology, that would be enhanced by an on- site CRC. In order to develop a greater breadth of clinical activities and allow formation of a cadre of active research faculty who are competitive for extramural funding, support is requested for the following 3 pilot projects: 1)The Effects of Angiotensin Converting Enzyme (ACE)on the Inhibition of the Progression of Diabetic Retinopathy; 2) Steroid Treatment in Premature Infants at Risk for Bronchopulmonary Dysplasia; and 3) Yq Microdeltetions and Male Infertility. In summary, specific goals of this application include: 1. To develop an infrastructure to facilitate clinical research at Drew University. 2. To expand the Core laboratory by enhancing its hormone and radioimmunoassay capabilities. 3. To initiate pilot investigative studies related to the health of minority populations. 4. To increase the number of extramural funded clinical investigators. 5. To encourage collaborative research between faculty at Drew University, Harbor-ACLU and ACLU. 6. To develop a """"""""Basic Science Foundations for Clinical Research"""""""" lecture series.

Agency
National Institute of Health (NIH)
Institute
National Center for Research Resources (NCRR)
Type
Exploratory Grants (P20)
Project #
3P20RR011145-04S2
Application #
2731561
Study Section
Special Emphasis Panel (ZRR1-RCMI-7 (01))
Project Start
1995-09-30
Project End
2000-08-31
Budget Start
1998-09-30
Budget End
1999-08-31
Support Year
4
Fiscal Year
1998
Total Cost
Indirect Cost
Name
Charles R. Drew University of Medicine & Science
Department
Type
Schools of Medicine
DUNS #
785877408
City
Los Angeles
State
CA
Country
United States
Zip Code
90059
Grams, Morgan E; Sang, Yingying; Ballew, Shoshana H et al. (2018) Predicting timing of clinical outcomes in patients with chronic kidney disease and severely decreased glomerular filtration rate. Kidney Int 93:1442-1451
Inker, Lesley A; Grams, Morgan E; Levey, Andrew S et al. (2018) Relationship of Estimated GFR and Albuminuria to Concurrent Laboratory Abnormalities: An Individual Participant Data Meta-analysis in a Global Consortium. Am J Kidney Dis :
Juraschek, Stephen P; Miller 3rd, Edgar R; Appel, Lawrence J (2018) Orthostatic Hypotension and Symptoms in the AASK Trial. Am J Hypertens 31:665-671
Chen, Teresa K; Appel, Lawrence J; Grams, Morgan E et al. (2017) APOL1 Risk Variants and Cardiovascular Disease: Results From the AASK (African American Study of Kidney Disease and Hypertension). Arterioscler Thromb Vasc Biol 37:1765-1769
Juraschek, Stephen P; Appel, Lawrence J; Miller 3rd, Edgar R (2017) Metoprolol Increases Uric Acid and Risk of Gout in African Americans With Chronic Kidney Disease Attributed to Hypertension. Am J Hypertens 30:871-875
Chen, Teresa K; Tin, Adrienne; Peralta, Carmen A et al. (2017) APOL1 Risk Variants, Incident Proteinuria, and Subsequent eGFR Decline in Blacks with Hypertension-Attributed CKD. Clin J Am Soc Nephrol 12:1771-1777
Liang, Su; Bian, Xiaomei; Liang, Dong et al. (2016) Solution formulation development and efficacy of MJC13 in a preclinical model of castration-resistant prostate cancer. Pharm Dev Technol 21:121-6
Chen, Teresa K; Choi, Michael J; Kao, W H Linda et al. (2015) Examination of Potential Modifiers of the Association of APOL1 Alleles with CKD Progression. Clin J Am Soc Nephrol 10:2128-35
Chen, Teresa K; Estrella, Michelle M; Astor, Brad C et al. (2015) Longitudinal changes in hematocrit in hypertensive chronic kidney disease: results from the African-American Study of Kidney Disease and Hypertension (AASK). Nephrol Dial Transplant 30:1329-35
Chang, Alex; Greene, Tom H; Wang, Xuelei et al. (2015) The effects of weight change on glomerular filtration rate. Nephrol Dial Transplant 30:1870-7

Showing the most recent 10 out of 146 publications